Circulation Cardiovascular Quality and Outcomes
-
Publication Venue For
-
Electronic Health Record Integration of Predictive Analytics to Select High-Risk Stable Patients With Non-ST-Segment-Elevation Myocardial Infarction for Intensive Care Unit Admission..
14:e007602.
2021
-
Standardizing ST-Segment Elevation Myocardial Infarction Care: Customizing Regionalization to Improve Outcomes..
14:e007701.
2021
-
Perceived Versus Actual Risks of 30-Day Readmission in Patients With Cardiovascular Disease..
14:e006586.
2021
-
Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction..
13:e007094.
2020
-
Site-Level Variability in 30-Day Patient Outcomes After Transcatheter Mitral Valve Repair in the United States..
13:e006878.
2020
-
Target: Stroke Was Associated With Faster Intravenous Thrombolysis and Improved One-Year Outcomes for Acute Ischemic Stroke in Medicare Beneficiaries..
13:e007150.
2020
-
Cause of Death Among Patients With Peripheral Artery Disease: Insights From the EUCLID Trial..
13:e006550.
2020
-
Recommendations for Reporting Machine Learning Analyses in Clinical Research..
13:e006556.
2020
-
Association of Hypertension and Arterial Blood Pressure on Limb and Cardiovascular Outcomes in Symptomatic Peripheral Artery Disease: The EUCLID Trial..
13:e006512.
2020
-
Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization..
13:e006582.
2020
-
Transcatheter Aortic Valve Replacement in Low-Population Density Areas: Assessing Healthcare Access for Older Adults With Severe Aortic Stenosis..
13:e006245.
2020
-
Catheterization Laboratory Activation Time in Patients Transferred With ST-Segment-Elevation Myocardial Infarction: Insights From the Mission: Lifeline STEMI Accelerator-2 Project..
13:e006204.
2020
-
Frontiers of Upstream Stroke Prevention and Reduced Stroke Inequity Through Predicting, Preventing, and Managing Hypertension and Atrial Fibrillation: A Call to Action From the Value in Healthcare Initiative's Predict & Prevent Learning Collaborative..
13:e006780.
2020
-
Improving Cardiovascular Drug and Device Development and Evidence Through Patient-Centered Research and Clinical Trials: A Call to Action From the Value in Healthcare Initiative's Partnering With Regulators Learning Collaborative..
13:e006606.
2020
-
Incidence and Factors Associated With Major Amputation in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial..
13:e006399.
2020
-
Value in Healthcare Initiative: Summary and Key Recommendations..
13:e006612.
2020
-
Computable Phenotype Implementation for a National, Multicenter Pragmatic Clinical Trial: Lessons Learned From ADAPTABLE..
13:e006292.
2020
-
Data Quarantine in the Time of the COVID-19 Pandemic..
13:e006908.
2020
-
Randomized Pragmatic Trial of Stroke Transitional Care: The COMPASS Study..
13:e006285.
2020
-
ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy..
13:e006834.
2020
-
Copayment Reduction Voucher Utilization and Associations With Medication Persistence and Clinical Outcomes: Findings From the ARTEMIS Trial..
13:e006182.
2020
-
The PCORnet Blood Pressure Control Laboratory: A Platform for Surveillance and Efficient Trials..
13:e006115.
2020
-
Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 Months: Findings From Get With The Guidelines-Stroke..
13:e006031.
2020
-
Fragility Index in Cardiovascular Randomized Controlled Trials..
12:e005755.
2019
-
Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial..
12:e005858.
2019
-
Baseline Predictors of Low-Density Lipoprotein Cholesterol and Systolic Blood Pressure Goal Attainment After 1 Year in the ISCHEMIA Trial..
12:e006002.
2019
-
Sex-Based Differences in Presentation, Treatment, and Complications Among Older Adults Hospitalized for Acute Myocardial Infarction: The SILVER-AMI Study..
12:e005691.
2019
-
Intravenous Tissue Plasminogen Activator in Stroke Mimics..
12:e005609.
2019
-
Comparative Effectiveness of β-Blocker Use Beyond 3 Years After Myocardial Infarction and Long-Term Outcomes Among Elderly Patients..
12:e005103.
2019
-
Assessing the Quality of Abstracts in Randomized Controlled Trials Published in High Impact Cardiovascular Journals..
12:e005260.
2019
-
Defining Clinically Important Difference in the Atrial Fibrillation Effect on Quality-of-Life Score..
12:e005358.
2019
-
Thirty-Day Readmission Risk Model for Older Adults Hospitalized With Acute Myocardial Infarction..
12:e005320.
2019
-
Epidemiology of Shock in Contemporary Cardiac Intensive Care Units..
12:e005618.
2019
-
Policing or Learning?.
12:e005484.
2019
-
PREPARED Study: A Study of Shared Decision-Making for Coronary Artery Disease..
12:e005244.
2019
-
Medication Discontinuation in the IMPROVE-IT Trial..
12:e005041.
2019
-
Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk..
12:e004945.
2019
-
Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes..
11:e004755.
2018
-
Evidence-Based Performance Measures and Outcomes in Patients With Acute Ischemic Stroke..
11:e001968.
2018
-
The Need for Speed..
11:e005234.
2018
-
Transcatheter Aortic Valve Replacement in the Era of Quality Assessment..
11:e005233.
2018
-
Cost-Effectiveness of Mitral Valve Repair Versus Replacement for Severe Ischemic Mitral Regurgitation: A Randomized Clinical Trial From the Cardiothoracic Surgical Trials Network.
11:e004466.
2018
-
Collaborative Quality Improvement Reduces Postoperative Pneumonia After Isolated Coronary Artery Bypass Grafting Surgery..
11:e004756.
2018
-
Predicting Quality of Life at 1 Year After Transcatheter Aortic Valve Replacement in a Real-World Population..
11:e004693.
2018
-
Is Anticoagulation Beneficial in Pulmonary Arterial Hypertension?.
11:e004757.
2018
-
Rates, Characteristics, and Outcomes of Patients Transferred to Specialized Stroke Centers for Advanced Care..
11:e003359.
2018
-
COMPASS-CP: An Electronic Application to Capture Patient-Reported Outcomes to Develop Actionable Stroke and Transient Ischemic Attack Care Plans..
11:e004444.
2018
-
First Medical Contact-to-Device Time and Heart Failure Outcomes Among Patients Undergoing Primary Percutaneous Coronary Intervention..
11:e004699.
2018
-
Gender Disparities Among Adult Recipients of Bystander Cardiopulmonary Resuscitation in the Public..
11:e004710.
2018
-
Association of the Affordable Care Act's Medicaid Expansion With Care Quality and Outcomes for Low-Income Patients Hospitalized With Heart Failure..
11:e004729.
2018
-
Differences Between Patients Enrolled Early and Late During Clinical Trial Recruitment: Insights From the HF-ACTION Trial..
11:e004643.
2018
-
Adverse Change in Employment Status After Acute Myocardial Infarction: Analysis From the TRANSLATE-ACS Study..
11:e004528.
2018
-
Comparison of Acute Ischemic Stroke Care and Outcomes Between Comprehensive Stroke Centers and Primary Stroke Centers in the United States..
11:e004512.
2018
-
Neighborhood Socioeconomic Disadvantage and Care After Myocardial Infarction in the National Cardiovascular Data Registry..
11:e004054.
2018
-
ISCHEMIA: Establishing the Primary End Point..
11:e004791.
2018
-
An Observational Study of the Association of Video- Versus Text-Based Informed Consent With Multicenter Trial Enrollment: Lessons From the PALM Study (Patient and Provider Assessment of Lipid Management)..
11:e004675.
2018
-
Health Status Variation Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF (Change the Management of Patients With Heart Failure) Registry..
11:e004668.
2018
-
Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry..
11:e004249.
2018
-
PORTRAIT (Patient-Centered Outcomes Related to Treatment Practices in Peripheral Arterial Disease: Investigating Trajectories): Overview of Design and Rationale of an International Prospective Peripheral Arterial Disease Study..
11:e003860.
2018
-
Importance and Challenges of Moving Stroke Prevention into the Community..
11:e004513.
2018
-
Mortality of Myocardial Infarction by Sex, Age, and Obstructive Coronary Artery Disease Status in the ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines)..
10:e003443.
2017
-
2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures..
10.
2017
-
Is Risk-Standardized In-Hospital Stroke Mortality an Adequate Proxy for Risk-Standardized 30-Day Stroke Mortality Data? Findings From Get With The Guidelines-Stroke..
10.
2017
-
Practice Patterns and In-Hospital Outcomes Associated With Bivalirudin Use Among Patients With Non-ST-Segment-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the United States..
10.
2017
-
2017 AHA/ACC Key Data Elements and Definitions for Ambulatory Electronic Health Records in Pediatric and Congenital Cardiology A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards.
10:1-+.
2017
-
Morbidity and Mortality Conference for Percutaneous Coronary Intervention..
10.
2017
-
Organizational Structure, Staffing, Resources, and Educational Initiatives in Cardiac Intensive Care Units in the United States: An American Heart Association Acute Cardiac Care Committee and American College of Cardiology Critical Care Cardiology Working Group Cross-Sectional Survey..
10:e003864.
2017
-
Regional Variation in 30-Day Ischemic Stroke Outcomes for Medicare Beneficiaries Treated in Get With The Guidelines-Stroke Hospitals..
10.
2017
-
Utilization, Characteristics, and In-Hospital Outcomes of Coronary Artery Bypass Grafting in Patients With ST-Segment-Elevation Myocardial Infarction: Results From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines..
10.
2017
-
2015 Revised Utstein-Style Recommended Guidelines for Uniform Reporting of Data From Drowning-Related Resuscitation: An ILCOR Advisory Statement..
10.
2017
-
Association of Surgeon Age and Experience With Congenital Heart Surgery Outcomes..
10.
2017
-
Priorities for Cardiovascular Outcomes Research: A Report of the National Heart, Lung, and Blood Institute's Centers for Cardiovascular Outcomes Research Working Group..
10.
2017
-
Direct Transport to a Percutaneous Cardiac Intervention Center and Outcomes in Patients With Out-of-Hospital Cardiac Arrest..
10.
2017
-
Putting Prognosis Into Perspective..
10.
2017
-
Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Assessment: Analysis From the National Cardiovascular Data Registry's Outpatient Practice Innovation and Clinical Excellence Atrial Fibrillation Registry..
10.
2017
-
Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)..
10.
2017
-
Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)..
10.
2017
-
Timely Reperfusion in Stroke and Myocardial Infarction Is Not Correlated: An Opportunity for Better Coordination of Acute Care..
10.
2017
-
Academic Outcomes in Children With Congenital Heart Defects: A Population-Based Cohort Study..
10.
2017
-
2016 AHA/ACC Clinical Performance and Quality Measures for Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures..
10:e000022.
2017
-
Characterization of Mineralocorticoid Receptor Antagonist Therapy Initiation in High-Risk Patients With Heart Failure..
10.
2017
-
Hospital Variation in Functional Recovery After Stroke..
10.
2017
-
Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke..
10.
2017
-
Few Disparities in Baseline Laboratory Testing After the Diuretic or Digoxin Initiation by Medicare Fee-For-Service Beneficiaries..
9:714-722.
2016
-
Guideline-Appropriate Care and In-Hospital Outcomes in Patients With Heart Failure in Teaching and Nonteaching Hospitals: Findings From Get With The Guidelines-Heart Failure..
9:757-766.
2016
-
Health Status Outcomes in Patients With Acute Myocardial Infarction After Rehospitalization..
9:777-784.
2016
-
Video-Only Cardiopulmonary Resuscitation Education for High-Risk Families Before Hospital Discharge: A Multicenter Pragmatic Trial..
9:740-748.
2016
-
Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease..
9:513-522.
2016
-
Predictors of Physician Under-Recognition of Angina in Outpatients With Stable Coronary Artery Disease..
9:554-559.
2016
-
Variation in Hospital Risk-Adjusted Mortality Rates Following Transcatheter Aortic Valve Replacement in the United States: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry..
9:560-565.
2016
-
2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures..
9:443-488.
2016
-
Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG)..
9:197-205.
2016
-
Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses: A Meta-Analysis..
9:294-302.
2016
-
Short-Term Risk of Serious Fall Injuries in Older Adults Initiating and Intensifying Treatment With Antihypertensive Medication..
9:222-229.
2016
-
Care Transitions After Acute Myocardial Infarction for Transferred-In Versus Direct-Arrival Patients..
9:109-116.
2016
-
Sex and Race/Ethnicity-Related Disparities in Care and Outcomes After Hospitalization for Coronary Artery Disease Among Older Adults..
9:S36-S44.
2016
-
2015 ACC/AHA Focused Update of Secondary Prevention Lipid Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures..
9:68-95.
2016
-
Quality Improvement Interventions to Improve Appropriateness of Imaging Studies: Necessary, But Are They Sufficient?.
9:2-4.
2016
-
ACC/AHA/STS Statement on the Future of Registries and the Performance Measurement Enterprise: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and The Society of Thoracic Surgeons..
8:634-648.
2015
-
Association of Patient Enrollment in Medicare Part D With Outcomes After Acute Myocardial Infarction..
8:567-575.
2015
-
Depressive Symptoms and Risk of Cardiovascular Events in Blacks: Findings From the Jackson Heart Study..
8:552-559.
2015
-
Modest Associations Between Electronic Health Record Use and Acute Myocardial Infarction Quality of Care and Outcomes: Results From the National Cardiovascular Data Registry..
8:576-585.
2015
-
Older Adults in Clinical Research and Drug Development: Closing the Geriatric Gap..
8:631-633.
2015
-
Chronic Stroke Outcome Measures for Motor Function Intervention Trials: Expert Panel Recommendations..
8:S163-S169.
2015
-
Quality of Care and Ischemic Stroke Risk After Hospitalization for Transient Ischemic Attack: Findings From Get With The Guidelines-Stroke..
8:S117-S124.
2015
-
Smoking Paradox in Patients Hospitalized With Coronary Artery Disease or Acute Ischemic Stroke: Findings From Get With The Guidelines..
8:S73-S80.
2015
-
Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)..
8:393-402.
2015
-
Cluster-Randomized Trial of Personalized Site Performance Feedback in Get With The Guidelines-Heart Failure..
8:421-427.
2015
-
Early Medication Nonadherence After Acute Myocardial Infarction: Insights into Actionable Opportunities From the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) Study..
8:347-356.
2015
-
Novel Oral Anticoagulant Use Among Patients With Atrial Fibrillation Hospitalized With Ischemic Stroke or Transient Ischemic Attack..
8:383-392.
2015
-
Sex-Stratified Trends in Enrollment, Patient Characteristics, Treatment, and Outcomes Among Non-ST-Segment Elevation Acute Coronary Syndrome Patients: Insights From Clinical Trials Over 17 Years..
8:357-367.
2015
-
Association between divorce and risks for acute myocardial infarction..
8:244-251.
2015
-
Comparisons of hospitalization rates among younger atrial fibrillation patients receiving different antiarrhythmic drugs..
8:292-300.
2015
-
Quantifying the utility of taking pills for cardiovascular prevention..
8:155-163.
2015
-
Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials..
8:179-186.
2015
-
Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic review..
8:47-55.
2015
-
Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry..
8:96-102.
2015
-
Identification of hospital outliers in bleeding complications after percutaneous coronary intervention..
8:15-22.
2015
-
Check it, change it: a community-based, multifaceted intervention to improve blood pressure control..
7:828-834.
2014
-
Chronic kidney disease and bleeding complications after intravenous thrombolytic therapy for acute ischemic stroke..
7:929-935.
2014
-
Clinical commentary on "Certain uncertainty: life after stroke from the patient's perspective"..
7:970.
2014
-
Readmission rates and long-term hospital costs among survivors of an in-hospital cardiac arrest..
7:889-895.
2014
-
Associations between anticoagulation therapy and risks of mortality and readmission among patients with heart failure and atrial fibrillation..
7:670-679.
2014
-
Contemporary patterns of discharge aspirin dosing after acute myocardial infarction in the United States: results from the National Cardiovascular Data Registry (NCDR)..
7:701-707.
2014
-
Examination of the treatment selection process in a multicenter observational study..
7:764-769.
2014
-
Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation..
7:770-777.
2014
-
Impact of time of presentation on process performance and outcomes in ST-segment-elevation myocardial infarction: a report from the American Heart Association: Mission Lifeline program..
7:656-663.
2014
-
Change in hospital-level use of transradial percutaneous coronary intervention and periprocedural outcomes: insights from the national cardiovascular data registry..
7:550-559.
2014
-
Quality-of-life outcomes with a disodium EDTA chelation regimen for coronary disease: results from the trial to assess chelation therapy randomized trial..
7:508-516.
2014
-
Insurance status is associated with acuity of presentation and outcomes for thoracic aortic operations..
7:398-406.
2014
-
Do the benefits of participation in a hypertension self-management trial persist after patients resume usual care?.
7:269-275.
2014
-
Representativeness of RELAX-AHF clinical trial population in acute heart failure..
7:259-268.
2014
-
Sources of hospital-level variation in major bleeding among patients with non-st-segment elevation myocardial infarction: a report from the National Cardiovascular Data Registry (NCDR)..
7:236-243.
2014
-
Use of renin-angiotensin system blockers in acute coronary syndromes: findings from Get With the Guidelines-Coronary Artery Disease Program..
7:227-235.
2014
-
Association of body mass index and long-term outcomes in older patients with non-ST-segment-elevation myocardial infarction: results from the CRUSADE Registry..
7:102-109.
2014
-
Peripheral arterial testing before lower extremity amputation among Medicare beneficiaries, 2000 to 2010..
7:142-150.
2014
-
The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT)..
7:15-24.
2014
-
Association between perceived life chaos and medication adherence in a postmyocardial infarction population..
6:619-625.
2013
-
Check it, change it: a community-based intervention to improve blood pressure control..
6:741-748.
2013
-
Differences in the profile, treatment, and prognosis of patients with cardiogenic shock by myocardial infarction classification: A report from NCDR..
6:708-715.
2013
-
Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF)..
6:534-542.
2013
-
Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin..
6:567-574.
2013
-
End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience..
6:470-478.
2013
-
Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry..
6:461-469.
2013
-
Ischemia-driven revascularization: demonstrating and delivering a mature procedure in a mature way..
6:250-252.
2013
-
Long-term outcomes after invasive management for older patients with non-ST-segment elevation myocardial infarction..
6:323-332.
2013
-
Patterns of emergency medical services use and its association with timely stroke treatment: findings from Get With the Guidelines-Stroke..
6:262-269.
2013
-
Racial and ethnic differences in outcomes in older patients with acute ischemic stroke..
6:284-292.
2013
-
Critical care cardiology research: a call to action..
6:237-242.
2013
-
Priorities for comparative effectiveness reviews in cardiovascular disease..
6:139-147.
2013
-
Achievement of guideline-concordant care and in-hospital outcomes in patients with coronary artery disease in teaching and nonteaching hospitals: results from the Get With The Guidelines-Coronary Artery Disease program..
6:58-65.
2013
-
Evaluating the impact of public health notification: Duke clopidogrel experience..
5:767-774.
2012
-
Left and codominant coronary artery circulations are associated with higher in-hospital mortality among patients undergoing percutaneous coronary intervention for acute coronary syndromes: report From the National Cardiovascular Database Cath Percutaneous Coronary Intervention (CathPCI) Registry..
5:775-782.
2012
-
Guideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarction..
5:654-661.
2012
-
Left ventricular ejection fraction assessment among patients with acute myocardial infarction and its association with hospital quality of care and evidence-based therapy use..
5:662-671.
2012
-
Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial..
5:680-688.
2012
-
Clopidogrel use and hospital quality in medically managed patients with non-ST-segment-elevation myocardial infarction..
5:523-531.
2012
-
Defining heart failure end points in ST-segment elevation myocardial infarction trials: integrating past experiences to chart a path forward..
5:594-600.
2012
-
Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke..
5:514-522.
2012
-
Patient-centered adherence intervention after acute coronary syndrome hospitalization..
5:571-576.
2012
-
Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction..
5:541-549.
2012
-
Systems of care for ST-segment-elevation myocardial infarction: a report From the American Heart Association's Mission: Lifeline..
5:423-428.
2012
-
Transfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI insights..
5:437-444.
2012
-
Hospital percutaneous coronary intervention appropriateness and in-hospital procedural outcomes: insights from the NCDR..
5:290-297.
2012
-
Hypertension control among patients followed by cardiologists..
5:352-357.
2012
-
Addition of frailty and disability to cardiac surgery risk scores identifies elderly patients at high risk of mortality or major morbidity..
5:222-228.
2012
-
Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial..
5:205-213.
2012
-
Care and outcomes of Asian-American acute myocardial infarction patients: findings from the American Heart Association Get With The Guidelines-Coronary Artery Disease program..
5:126-133.
2012
-
Get With The Guidelines program participation, process of care, and outcome for Medicare patients hospitalized with heart failure..
5:37-43.
2012
-
High risk percutaneous coronary intervention and intra-aortic balloon pumps: when is the safety net needed?.
5:12-13.
2012
-
Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007..
5:85-93.
2012
-
Introduction of the Tools for Economic Analysis of Patient Management Interventions in Heart Failure Costing Tool: a user-friendly spreadsheet program to estimate costs of providing patient-centered interventions..
5:113-119.
2012
-
Linking the National Cardiovascular Data Registry CathPCI Registry with Medicare claims data: validation of a longitudinal cohort of elderly patients undergoing cardiac catheterization..
5:134-140.
2012
-
Comparison of composite measure methodologies for rewarding quality of care: an analysis from the American Heart Association's Get With The Guidelines program..
4:610-618.
2011
-
Use of early clopidogrel by reperfusion strategy among patients presenting with ST-segment elevation myocardial infarction..
4:603-609.
2011
-
Care processes associated with quicker door-in-door-out times for patients with ST-elevation-myocardial infarction requiring transfer: results from a statewide regionalization program..
4:382-388.
2011
-
Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials..
4:448-458.
2011
-
Center variation in hospital costs for patients undergoing congenital heart surgery..
4:306-312.
2011
-
Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction..
4:146-151.
2011
-
Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial..
4:183-192.
2011
-
Secondary prevention risk interventions via telemedicine and tailored patient education (SPRITE): a randomized trial to improve postmyocardial infarction management..
4:235-242.
2011
-
The impact of postrandomization crossover of therapy in acute coronary syndromes care..
4:211-219.
2011
-
Toward more optimal use of primary prevention implantable cardioverter-defibrillators: how do we get there?.
4:140-142.
2011
-
Assessment of left ventricular function in older Medicare beneficiaries with newly diagnosed heart failure..
4:85-91.
2011
-
Incremental value of clinical data beyond claims data in predicting 30-day outcomes after heart failure hospitalization..
4:60-67.
2011
-
Randomized trial of targeted performance feedback to facilitate quality improvement in acute myocardial infarction care..
4:129-135.
2011
-
Use of antithrombotic medications among elderly ischemic stroke patients..
4:30-38.
2011
-
Geographic variation and trends in carotid imaging among medicare beneficiaries, 2001 to 2006..
3:599-606.
2010
-
Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry..
3:632-641.
2010
-
Impact of a statewide ST-segment-elevation myocardial infarction regionalization program on treatment times for women, minorities, and the elderly..
3:514-521.
2010
-
Cost-effectiveness of targeting patients undergoing percutaneous coronary intervention for therapy with bivalirudin versus heparin monotherapy according to predicted risk of bleeding..
3:358-365.
2010
-
Economic evaluation of the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) randomized controlled trial: an exercise training study of patients with chronic heart failure..
3:374-381.
2010
-
Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarction..
3:337-346.
2010
-
Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery system..
3:303-308.
2010
-
Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke..
3:291-302.
2010
-
Cognitive function and anticoagulation control in patients with atrial fibrillation..
3:277-283.
2010
-
Treatment and risk in heart failure: gaps in evidence or quality?.
3:309-315.
2010
-
Patient reactions to confidentiality, liability, and financial aspects of informed consent in cardiology research..
3:151-158.
2010
-
Patient satisfaction and its relationship with clinical quality and inpatient mortality in acute myocardial infarction..
3:188-195.
2010
-
Representation of women in randomized clinical trials of cardiovascular disease prevention..
3:135-142.
2010
-
Twelve-year follow-up of American women's awareness of cardiovascular disease risk and barriers to heart health..
3:120-127.
2010
-
A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program..
3:25-32.
2010
-
Costs of inpatient care among Medicare beneficiaries with heart failure, 2001 to 2004..
3:33-40.
2010
-
Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes..
2:583-590.
2009
-
Trends in the use of evidence-based treatments for coronary artery disease among women and the elderly: findings from the get with the guidelines quality-improvement program..
2:633-641.
2009
-
A call to ACTION (acute coronary treatment and intervention outcomes network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction..
2:491-499.
2009
-
Temporal changes in the use of drug-eluting stents for patients with non-ST-Segment-elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008: results from the can rapid risk stratification of unstable angina patients supress ADverse outcomes with early implementation of the ACC/AHA guidelines (CRUSADE) and acute coronary treatment and intervention outcomes network-get with the guidelines (ACTION-GWTG) registries..
2:414-420.
2009
-
Angiographic profiles in courage..
2:292-293.
2009
-
Increasing healthcare resource utilization after coronary artery bypass graft surgery in the United States..
2:305-312.
2009
-
Representativeness of a national heart failure quality-of-care registry: comparison of OPTIMIZE-HF and non-OPTIMIZE-HF Medicare patients..
2:377-384.
2009
-
Use of guidelines-recommended management and outcomes among women and men with low-level troponin elevation: insights from CRUSADE..
2:199-206.
2009
-
C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study..
1:92-97.
2008
-
Prevention of future cardiovascular disease in high-risk pediatric patients: a role for lipid lowering therapy?.
1:131-133.
2008
-
Informing the consent process..
1:7-8.
2008